Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin

Journal of Clinical Investigation

Volumn 114, Issue 5, 2004, Pages 652-658

  Rahmouni, Kamal ^a   Morgan, Donald A ^a   Morgan, Gina M ^a   Liu, Xuebo ^a   Sigmund, Curt D ^a   Mark, Allyn L ^a   Haynes, William G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CORTICOTROPIN RELEASING FACTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; P85 ALPHA PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P42; PROTEIN P44; PROTEIN P85; TYROSINE; UNCLASSIFIED DRUG; WORTMANNIN;

ADRENAL GLAND; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; EX VIVO STUDY; HINDLIMB; HYPOTHALAMUS; INSULIN RESPONSE; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; SYMPATHETIC TONE; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; INNERVATION; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE TISSUE, BROWN; ADRENAL GLANDS; ANIMALS; HINDLIMB; HYPOTHALAMUS; INSULIN; KIDNEY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 85047693533     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21737     Document Type: Article

References (41)

1. Rowe J.W., et al. 1981. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219-225.
2. Liang, C., et al. 1982. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J. Clin. Invest. 69:1321-1336.
3. Lembo, G., et al. 1992. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J. Clin. Invest. 90:24-29.
4. Tomiyama, H., et al. 1992. Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats. Hypertension. 20:596-600.
5. Anderson, E.A., Hoffman, R.P., Balon, T.W., Sinkey, C.A., and Mark, A.L. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87: 2246-2252.
6. Vollenweider, L., et al. 1995. Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes. 44:641-645.
7. Morgan, D.A., Balon, T.W., Ginsberg, B.H., and Mark, A.L. 1993. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am. J. Physiol. 264:R423-R427.
8. Muntzel, M.S., Morgan, D.A., Mark, A.L., and Johnson, A.K. 1994. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J. Physiol. 267:R1350-R1355.
9. Muntzel, M., Beltz, T., Mark, A.L., and Johnson, A.K. 1994. Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. Hypertension. 23:1059-1062.
10. Havrankova, J., Roth, J., and Brownstein, M. 1978. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 272:827-829.
11. Werther, G.A., et al. 1987. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro au to radiography and computerized densitometry. Endocrinology. 121:1562-1570.
12. Zhao, W.Q., and Alkon, D.L. 2001. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol 177:125-134.
13. Saltiel, A.R., and Kahn, C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:799-806.
14. Baumann, C.A., and Saltiel, A.R. 2001. Spatial compartmentalization of signal transduction in insulin action. Bioessays. 23:215-222.
15. Shepherd, P.R., Withers, D.J., and Siddle, K. 1998. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333:471-490.
16. Correia, M.L., et al. 2001. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension. 38:384-388.
17. Berne, C., Fagius, J., Pollare, T., and Hjemdahl, P. 1992. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873-879.
18. Scherrer, U., and Sartori, C. 1997. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 96:4104-4113.
19. Benoit, S.C., Clegg, D.J., Seeley, R.J., and Woods, S.C. 2004. Insulin and leptin as adiposity signals. Recent Prog. Horm. Res. 59:267-285.
20. Obici, S., Feng, Z., Karkanias, G., Baskin, D.G., and Rossetti, L. 2002. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5:566-572.
21. Bruning, J.C., et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2122-2125.
22. Menendez, J.A., and Atrens, D.M. 1991. Insulin and the paraventricular hypothalamus: modulation of energy balance. Brain Res. 555:193-201.
23. Geloen, A., and Trayhurn, P. 1990. Regulation of the level of uncoupling protein in brown adipose tissue by insulin requires the mediation of the sympathetic nervous system. FEBS Lett. 267:265-267.
24. Obici, S., Zhang, B.B., Karkanias, G., and Rossetti., L. 2002. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8:1376-1382.
25. Szabo, A.J., and Szabo, O, 1983. Insulin injected into CNS structures or into the carotid artery: effect on carbohydrate homeostasis of the intact animal. Adv. Metab. Disord. 10:385-400.
26. Szabo, O., and Szabo, A.J. 1975. Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system. Diabetes. 24:328-336.
27. Edwards J.G., and Tipton, C.M. 1989. Influences of exogenous insulin on arterial blood pressure measurements of the rat. J. Appl. Physiol. 67:2335-2342.
28. Meehan, W.P., Buchanan, T.A., and Hsueh, W. 1994. Chronic insulin administration elevates blood pressure in rats. Hypertension. 23:1012-1017.
29. Rocchini, A.P., et al. 1989. Insulin and renal sodium retention in obese adolescents. Hypertension. 14:367-374.
30. Porter, J.P. 1994. Effect of intrahypothalamic insulin on sympathetic nervous function in rats drinking a high-sucrose solution. Am. J. Physiol. 266:R1463-R1469.
31. Landsberg, L. 2001. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J. Hypertens. 19:523-528.
32. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci. 3:757-758.
33. Niswender, K.D., et al. 2003. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes. 52:227-231.
34. Carvalheira, J.B., et al. 2003. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia. 46:1629-1640.
35. Benoit, S.C., et al. 2002. The catabolic action of insulin in the brain is mediated by melanocortins. J. Neurosci. 22:9048-9052.
36. Schwartz, M.W., et al. 1992. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:3608-3616.
37. Rahmouni, K., Haynes, W.G., Morgan, D.A., and Mark, A.L. 2003. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J. Neurosci. 23:5998-6004.
38. Davies, S.P., Reddy, H., Caivano, M., and Cohen, P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
39. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vicro and in vivo. J. Biol. Chem. 270:27489-27494.
40. Favata, M.F., et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632.
41. Morgan, D.A., Thoren, P., Staudt, S.M., and Mark, A.L. 1988. Differential effects of anesthesia on heart rate (HR), renal (RSNA), and lumbar sympathetic nerve activity (LSNA) in the rat [abstract]. FASEB J. 2:A1690.